NI
Nuance Investments Portfolio holdings
AUM
$588M
Turnover
30.36%
1-Year Est. Return
6.93%
This Fund
S&P 500
This Quarter
Est. Return
-2.09%
1 Year Est. Return
+6.93%
3 Year Est. Return
-3.13%
5 Year Est. Return
-5.61%
10 Year Est. Return
+43.7%
AUM
$1.54B
AUM Growth
+$54.8M
(+3.7%)
Cap. Flow
+$85.2M
Cap. Flow
% of AUM
5.55%
Top 10 Holdings %
Top 10 Hldgs %
46.44%
Holding
69
New
12
Increased
25
Reduced
21
Closed
11
Avg Time Held
1
year
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$58.6M |
| 2 |
Reinsurance Group of America
RGA
|
+$52.4M |
| 3 |
Unum
UNM
|
+$52M |
| 4 |
SAFM
Sanderson Farms Inc
SAFM
|
+$48M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$32.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Buffalo Pet Products, Inc
BUFF
|
+$56M |
| 2 |
Kimberly-Clark
KMB
|
+$44.7M |
| 3 |
OA
Orbital ATK, Inc.
OA
|
+$33.8M |
| 4 |
Colgate-Palmolive
CL
|
+$32M |
| 5 |
California Water Service
CWT
|
+$27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.81% |
| 2 | Healthcare | 27.23% |
| 3 | Consumer Staples | 12.38% |
| 4 | Technology | 9.19% |
| 5 | Real Estate | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Dentsply Sirona
XRAY
$1.68B
| $95.2M | 6.2% |
2,174,311
+1,247,670
| +135% | +$58.6M |
2018 Q1
1 quarter
|
|
|
SAFM
2
DELISTED
Sanderson Farms Inc
SAFM
| $82.2M | 5.35% |
781,526
+441,770
| +130% | +$48M |
2016 Q2
8 quarters
|
|
3
Smith & Nephew
SNN
$11.7B
| $80.4M | 5.23% |
2,141,401
-56,204
| -3% | -$2.09M |
2015 Q4
10 quarters
|
|
4
Travelers Companies
TRV
$78.8B
| $77.2M | 5.02% |
630,719
+88,049
| +16% | +$11.5M |
2016 Q2
8 quarters
|
|
|
CERN
5
DELISTED
Cerner Corp
CERN
| $70.7M | 4.61% |
1,182,995
+185,434
| +19% | +$11M |
2016 Q4
6 quarters
|
|
6
DELISTED
Equity Commonwealth
EQC
| $69.9M | 4.55% |
2,220,339
+289,572
| +15% | +$8.95M |
2017 Q3
3 quarters
|
|
|
7
Unum
UNM
$14.5B
| $66.7M | 4.34% |
1,802,312
+1,247,604
| +225% | +$52M |
2017 Q3
3 quarters
|
|
8
Becton Dickinson
BDX
$51.5B
| $58.6M | 3.82% |
250,839
-6,336
| -2% | -$1.41M |
2017 Q4
2 quarters
|
|
|
9
Reinsurance Group of America
RGA
$17B
| $57.7M | 3.76% |
432,328
+351,078
| +432% | +$52.4M |
2017 Q2
4 quarters
|
|
10
Amphenol
APH
$204B
| $54.8M | 3.57% |
5,026,608
+2,363,728
| +89% | +$25.7M |
2017 Q1
5 quarters
|
|
11
Diageo
DEO
$51.2B
| $51.4M | 3.35% |
356,956
-104,714
| -23% | -$15M |
2015 Q1
13 quarters
|
|
12
Everest Group
EG
$14.4B
| $50.4M | 3.28% |
218,557
+1,311
| +0.6% | +$308K |
2017 Q4
2 quarters
|
|
13
UMB Financial
UMBF
$9.79B
| $48.8M | 3.18% |
640,034
+20,160
| +3% | +$1.55M |
2017 Q2
4 quarters
|
|
14
MetLife
MET
$63.4B
| $48.1M | 3.13% |
1,104,129
-21,094
| -2% | -$983K |
2017 Q1
5 quarters
|
|
|
XLNX
15
DELISTED
Xilinx Inc
XLNX
| $42.3M | 2.76% |
648,682
+476,220
| +276% | +$32.5M |
2017 Q2
4 quarters
|
|
16
White Mountains Insurance
WTM
$5.01B
| $34.2M | 2.23% |
37,730
+17,099
| +83% | +$15.1M |
2017 Q4
2 quarters
|
|
|
ABAX
17
DELISTED
Abaxis Inc
ABAX
| $34M | 2.21% |
+409,577
| New | +$31.4M |
2018 Q2
0 quarters
|
|
18
Ecolab
ECL
$80.7B
| $33M | 2.15% |
234,986
+17,434
| +8% | +$2.51M |
2017 Q1
5 quarters
|
|
19
Universal Health Services
UHS
$11B
| $32.8M | 2.14% |
294,595
+218,556
| +287% | +$25.6M |
2017 Q3
3 quarters
|
|
20
Johnson & Johnson
JNJ
$612B
| $30.7M | 2% |
253,370
+102,321
| +68% | +$12.8M |
2017 Q1
5 quarters
|
|
21
Northern Trust
NTRS
$29.8B
| $28.4M | 1.85% |
275,583
-199,966
| -42% | -$21.2M |
2013 Q2
20 quarters
|
|
22
Chubb
CB
$135B
| $25.2M | 1.64% |
198,160
+51,179
| +35% | +$6.8M |
2017 Q2
4 quarters
|
|
23
HUB Group
HUBG
$1.61B
| $23.4M | 1.52% |
939,852
-299,516
| -24% | -$7.03M |
2015 Q2
12 quarters
|
|
24
AptarGroup
ATR
$7.65B
| $20.1M | 1.31% |
214,811
-2,861
| -1% | -$266K |
2016 Q3
7 quarters
|
|
25
Abbott
ABT
$178B
| $19.7M | 1.28% |
323,245
-116,325
| -26% | -$7.05M |
2016 Q4
6 quarters
|
|
Similar funds
TC
CFMC
NWA
WPP
SP
DCP
ROC
ETS
Nuance Investments's Q2 2018 Portfolio in Review
As of Q2 2018, Nuance Investments held 69 positions worth $1.54B, up 3.7% from $1.48B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Nuance Investments deployed $85.2M of net new capital in Q2 2018, opening 12 new positions and adding to 25 existing holdings. Its largest new stake was Abaxis Inc: 409,577 shares worth $34M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Kimberly-Clark, an estimated $44.7M trimmed.
- Nuance Investments's largest Q2 2018 buy was Abaxis Inc: 409,577 shares worth $34M.
- Nuance Investments added most to Dentsply Sirona in Q2 2018, an estimated $58.6M increase.
- Nuance Investments's biggest Q2 2018 reduction was Kimberly-Clark, cutting an estimated $44.7M.
- Nuance Investments fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $56M.
- Nuance Investments's ten largest holdings make up 46% of its $1.54B portfolio in Q2 2018.
- Nuance Investments opened 12 new positions and closed 11 in Q2 2018.
- Nuance Investments's portfolio value rose 3.7% quarter-over-quarter to $1.54B.
Based on Nuance Investments's 13F filing for Q2 2018, filed 10 Aug 2018.